Viewing Study NCT06582628


Ignite Creation Date: 2025-12-26 @ 10:36 AM
Ignite Modification Date: 2025-12-31 @ 2:14 PM
Study NCT ID: NCT06582628
Status: RECRUITING
Last Update Posted: 2024-12-02
First Post: 2024-08-30
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Talazoparib Plus Enzalutamide After Progression to Abiraterone in Metastatic Prostate Cancer: (TEAM PC)
Sponsor: Fundacion Oncosur
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module